Sino Total Cash From Financing Activities from 2010 to 2024

688108 Stock   11.00  0.21  1.87%   
Sino Medical's Total Cash From Financing Activities is decreasing over the years with slightly volatile fluctuation. Total Cash From Financing Activities is expected to dwindle to about 94.1 M. From 2010 to 2024 Sino Medical Total Cash From Financing Activities quarterly data regression line had arithmetic mean of  214,065,092 and r-squared of  0.55. View All Fundamentals
 
Total Cash From Financing Activities  
First Reported
2010-12-31
Previous Quarter
105.2 M
Current Value
94.1 M
Quarterly Volatility
148.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Sino Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sino Medical's main balance sheet or income statement drivers, such as Interest Expense of 2.8 M, Selling General Administrative of 82.7 M or Total Revenue of 246.2 M, as well as many indicators such as . Sino financial statements analysis is a perfect complement when working with Sino Medical Valuation or Volatility modules.
  
This module can also supplement various Sino Medical Technical models . Check out the analysis of Sino Medical Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Sino Stock

Sino Medical financial ratios help investors to determine whether Sino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sino with respect to the benefits of owning Sino Medical security.